Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06533670
TME Alteration in HER2 Positive Breast Cancer
Sponsor: Seoul National University Hospital
View on ClinicalTrials.gov
Summary
Evaluate for changes in the tumor microenvironment before/during neoadjuvant chemotherapy and after treatment in patients diagnosed with HER2-positive advanced breast cancer and receiving neoadjuvant cancer therapy and surgery for curative purposes.
Official title: Tumor Microenvironment Alteration During Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2024-07-19
Completion Date
2026-07-19
Last Updated
2026-01-28
Healthy Volunteers
No
Locations (1)
Seoul National University Hospital
Seoul, South Korea